SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-14-000461
Filing Date
2014-02-14
Accepted
2014-02-14 16:31:12
Documents
6
Period of Report
2014-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1400226_8k.htm 8-K 40256
2 EXHIBIT 3.1 t1400226_ex3-1.htm EX-3.1 44392
3 EXHIBIT 3.2 t1400226_ex3-2.htm EX-3.2 130132
4 EXHIBIT 99.1 t1400226_ex99-1.htm EX-99.1 10822
5 EXHIBIT 99.2 t1400226_ex99-2.htm EX-99.2 8093
6 GRAPHIC logo.jpg GRAPHIC 24898
  Complete submission text file 0001571049-14-000461.txt   269672
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 14617335
SIC: 2834 Pharmaceutical Preparations